The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls

Osteoporosis International

Volumn 16, Issue 12, 2005, Pages 1982-1988

  Hellström, Hans Olov ^a   Mjöberg, Bengt ^b   Mallmin, Hans ^a   Michaëlsson, Karl ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Ystad County Hospital   (Sweden)

Author keywords

Aluminum; Alzheimer's disease; Dementia; Hip fracture; Osteoporosis

Indexed keywords

ALUMINUM;

ADOLESCENT; ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BONE BIOPSY; CONTROLLED STUDY; DEMENTIA; FEMALE; HIP FRACTURE; HUMAN; HUMAN TISSUE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRABECULAR BONE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; ALUMINUM; ALZHEIMER DISEASE; BONE AND BONES; CREATININE; DEMENTIA; FEMALE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; SEX DISTRIBUTION;

EID: 29044436475     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-005-1981-6     Document Type: Article

References (55)

1. Alfrey AC (1983) Aluminum. Adv Clin Chem 23:69-91
2. Varo P, Koivistoinen P (1980) Mineral element composition of Finish foods. Acta Agric Scand 22:161-171
3. Drüeke TB (2002) Intestinal absorption of aluminum in renal failure. Nephrol Dial Transplant 17 [Suppl 2]:13-16
4. Priest ND (1999) Aluminum. Occurrence and toxicity. In: Sadler JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, San Diego, pp 59-66
5. Yokel RA, McNamara PJ (2001) Aluminum toxicokinetics: an updated minireview. Pharmacol Toxicol 88:159-167
6. Pérez-Granados AM, Vaquero MP (2002) Silicon, aluminum, arsenic and lithium: essentiality and human health implications. J Nutr Health Aging 6:154-162
7. Priest ND (2004) The biological behaviour and bioavailability of aluminum in man, with special reference to studies employing aluminum-26 as a tracer: review and study update. J Environ Monit 6:375-403
8. Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA (2000) Absorption of aluminum-26 in Alzheimer's disease, measured using accelerator mass spectrometry. Dement Geriatr Cognit Disord 11:66-69
9. Taylor GA, Ferrier IN, McLoughlin IJ, Fairbairn AF, McKeith IG, Lett D, Edwardson JA (1992) Gastrointestinal absorption of aluminum in Alzheimer's disease: response to aluminum citrate. Age Ageing 21:81-90
10. Alfrey AC (1987) Aluminum metabolism and toxicity in uremia. J UOEH [Suppl] 9:123-132
11. Alfrey AC, LeGendre GR, Kaehny WD (1976) The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 294:184-188
12. Berlyne GM (1970) Hyperaluminaemia from aluminum resins. Lancet 2:1253
13. Berlyne GM, Yagil R, Ari JB, Weinberger G, Knopf E, Danovitch GM (1972) Aluminum toxicity in rats. Lancet 1:564-568
14. Cannata-Andia JB, Fernandez-Martin JL (2002) The clinical impact of aluminum overload in renal failure. Nephrol Dial Transplant 17 [Suppl 2]:9-12
15. Hewitt CD, Savory J, Wills MR (1990) Aspects of aluminum toxicity. Clin Lab Med 10:403-422
16. Nebeker HG, Coburn JW (1986) Aluminum and renal osteodystrophy. Ann Rev Med 37:79-95
17. Parkinson IS, Ward MK, Feest TG, Fawcett RW, Kerr DN (1979) Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet 1:406-409
18. Sherrard DJ (1974) Letter: the myth of aluminum toxicity. N Engl J Med 290:750
19. Ward MK, Feest TG, Ellis HA, Parkinson IS, Kerr DN (1978) Osteomalacic dialysis osteodystrophy: evidence for a waterborne aetiological agent, probably aluminum. Lancet 1:841-845
20. Mjoberg B (1989) Aluminum-induced hip fractures: a hypothesis. J Bone Joint Surg Br 71:538
21. Mjoberg B, Hellquist E, Mallmin H, Lindh U (1997) Aluminum, Alzheimer's disease and bone fragility. Acta Orthop Scand 68:511-514
22. Klein GL (1995) Aluminum in parenteral solutions revisited - again. Am J Clin Nutr 61:449-456
23. Ott SM, Maloney NA, Klein GL, Alfrey AC, Ament ME, Coburn JW, Sherrard DJ (1983) Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Intern Med 98:910-914
24. Vargas JH, Klein GL, Ament ME, Ott SM, Sherrard DJ, Horst RL, Berquist WE, Alfrey AC, Slatopolsky E, Coburn JW (1988) Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. Am J Clin Nutr 48:1070-1078
25. Bush VJ, Moyer TP, Batts KP, Parisi JE (1995) Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues. Clin Chem 41:284-294
26. Tahán JE, Granadillo VA, Romero RA (1994) Electrothermal atomic absorption spectrometric determination of Al, Cu, Fe, Pb, V and Zn in clinical samples and in certified environmental reference materials. Anal Chim Acta 295:187-197
27. Tang S, Parsons PJ, Perl D (1999) Longitudinal and lateral variations in the aluminum concentration of selected caprine, bovine, and human bone samples. Biol Trace Elem Res 68:267-279
28. Campbell A (2002) The potential role of aluminum in Alzheimer's disease. Nephrol Dial Transplant 17 [Suppl 2]:17-20
29. Campbell A, Becaria A, Lahiri DK, Sharman K, Bondy SC (2004) Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res 75:565-572
30. Foster HD (2002) Why the preeminent risk factor in sporadic Alzheimer's disease cannot be genetic. Med Hypotheses 59:57-61
31. Grant WB, Campbell A, Itzhaki RF, Savory J (2002) The significance of environmental factors in the etiology of Alzheimer's disease. J Alzheimer Dis 4:179-189
32. Matsuzaki S, Manabe T, Katayama T, Nishikawa A, Yanagita T, Okuda H, Yasuda Y, Miyata S, Meshitsuka S, Tohyama M (2004) Metals accelerate production of the aberrant splicing isoform of the presenilin-2. J Neurochem 88:1345-1351
33. Pedersen NL, Gatz M, Berg S, Johansson B (2004) How heritable is Alzheimer's disease late in life? Findings from Swedish twins. Ann Neurol 55:180-185
34. Pedersen NL, Posner SF, Gatz M (2001) Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins. Am J Med Genet 105:724-728
35. Buchner DM, Larson EB (1987) Falls and fractures in patients with Alzheimer-type dementia. JAMA 257:1492-1495
36. Gruber-Baldini AL, Zimmerman S, Morrison RS, Grattan LM, Hebel JR, Dolan MM, Hawkes W, Magaziner J (2003) Cognitive impairment in hip fracture patients: timing of detection and longitudinal follow-up. J Am Geriatr Soc 51:1227-1236
37. Walter LC, Lui LY, Eng C, Covinsky KE (2003) Risk of hip fracture in disabled community-living older adults. J Am Geriatr Soc 51:50-55
38. Weller I, Schatzker J (2004) Hip fractures and Alzheimer's disease in elderly institutionalized Canadians. Ann Epidemiol 14:319-324
39. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
40. Hellstrom HO, Lindh U, Mjoberg B (2000) Measurement accuracy of aluminum content in bone. Ups J Med Sci 105:67-71
41. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761-1767
42. Gomez-Alonso C, Menendez-Rodriguez P, Virgos-Soriano MJ, Fernandez-Martin JL, Fernandez-Coto MT, Cannata-Andia JB (1999) Aluminum-induced osteogenesis in osteopenic rats with normal renal function. Calcif Tissue Int 64:534-541
43. Delmas PD, Recker RR, Chesnut CH 3, Skag A, Stakkestad JA, Emkey R, Gilbride J, Schimmer RC, Christiansen C (2004) Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporos Int 15:792-798
44. Quarles LD (1991) Paradoxical toxic and trophic osseous actions of aluminum: potential explanations. Miner Electrolyte Metab 17:233-239
45. Quarles LD, Gitelman HJ, Drezner MK (1989) Aluminum-induced de novo bone formation in the beagle. A parathyroid hormone-dependent event. J Clin Invest 83:1644-1650
46. Quarles LD, Murphy G, Vogler JB, Drezner MK (1990) Aluminum-induced neo-osteogenesis: a generalized process affecting trabecular networking in the axial skeleton. J Bone Miner Res 5:625-635
47. Rodriguez M, Felsenfeld AJ, Llach F (1990) Aluminum administration in the rat separately affects the osteoblast and bone mineralization. J Bone Miner Res 5:59-67
48. Zhu JM, Huffer W, Alfrey AC (1990) Effect of aluminum on bone matrix inductive properties. Kidney Int 38:1141-1145
49. Cumming RG, Klineberg RJ (1994) Aluminum in antacids and cooking pots and the risk of hip fractures in elderly people. Age Ageing 23:468-472
50. O'Mahony D, Denton J, Templar J, O'Hara M, Day JP, Murphy S, Walsh JB, Coakley D (1995) Bone aluminum content in Alzheimer's disease. Dementia 6:69-72
51. Ganrot PO (1986) Metabolism and possible health effects of aluminum. Environ Health Perspect 65:363-441
52. D'Haese PC, Couttenye MM, Lamberts LV, Elseviers MM, Goodman WG, Schrooten I, Cabrera WE, De Broe ME (1999) Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 45:1548-1556
53. Navarro JA, Granadillo VA, Salgado O, Rodriguez-Iturbe B, Garcia R, Delling G, Romero RA (1992) Bone metal content in patients with chronic renal failure. Clin Chim Acta 211:133-142
54. Paakari P, Anker Nielsen A, Lauritsen P, Morkore H, Voipio T, Sigfússon E, Litleskare I, Ericsson O, Nielsen J (2004) Medicines Consumption in the Nordic Countries 1999-2003, http://www.nom-nos.dk/ Medicinebook/medicines%20consumption.pdf. Schultz Information, Albertslund, Denmark
55. Pennington JA (1988) Aluminum content of foods and diets. Food Addit Contam 5:161-232